Antibodies to SARS-CoV-2 and risk of past or future sick leave

Antibodies to SARS-CoV-2 and risk of past or future sick leave

Abstract The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. We invited all employees (n = 15,300) at work at the Karolinska University Hospital, Stockholm, Sweden to participate in a study examining SARS-Cov-2 antibodies in relation to registered...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Joakim Dillner, K. Miriam Elfström, Jonas Blomqvist, Carina Eklund, Camilla Lagheden, Sara Nordqvist-Kleppe, Cecilia Hellström, Jennie Olofsson, Eni Andersson, August Jernbom Falk, Sofia Bergström, Emilie Hultin, Elisa Pin, Anna Månberg, Peter Nilsson, My Hedhammar, Sophia Hober, Johan Mattsson, Laila Sara Arroyo Mühr, Kalle Conneryd Lundgren
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Nature Portfolio 2021-03-01
Seri Bilgileri:Scientific Reports
Online Erişim:https://doi.org/10.1038/s41598-021-84356-w

Internet

https://doi.org/10.1038/s41598-021-84356-w

Benzer Materyaller